Summary Heart palpitations are relatively uncommon among semaglutide users, with one source reporting about 1% and broader summaries noting cardiovascular side effects under 5%, so most patients will not develop persistent arrhythmias
Our weight loss doctors will review your health history, discuss your goals, and explain which treatment options fit your situation
If you are pregnant, breast-feeding, taking medication or have a medical condition, please consult your doctor before use
India's drug regulator has intensified surveillance over GLP-1 weight loss drugs following the March patent expiry of semaglutide, which triggered a flood of more than 40 generic versions into the market
FAQ What are GLP-1 medications, and how do they work
Those reactions are more concerning if they worsen, spread, become hot, drain fluid, or come with fever or systemic symptoms